Risperidone – March 2026

Subcutaneous injection (modified release) 50 mg in 0.14 mL pre-filled syringe, Subcutaneous injection (modified release) 75 mg in 0.21 mL pre-filled syringe, Subcutaneous injection (modified release) 100 mg in 0.28 mL pre-filled syringe, Subcutaneous injection (modified release) 125 mg in 0.35 mL pre-filled syringe

  • Brand names:
    • Uzedy®
  • Pharmaceutical Company:
    • TEVA PHARMA AUSTRALIA PTY LTD
  • Condition/Indication: Schizophrenia
  • Meeting Date: March 2026

Last updated
11 March 2026